Skip to main content

AIFA - Allergy and Immunology Foundation of Australasia

AIFA - ACNC Registered Charity Organisationwww.allergyimmunology.org.au

 Donate to AIFA now 

On behalf of ASCIA and AIFA, organisations, companies and individuals are invited to support AIFA grants for allergy, immunodeficiency and autoimmunity clinical research in 2024-2025.

AIFA was established in 2013 by ASCIA with the aim to improve the health and care of people with allergy, immunodeficiency and other immune system disorders by funding medical research. These disorders are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population.

Due to generous support from ASCIA members, organisations, companies, families and community fundraisers, AIFA has awarded over $700,000 in research grants to 34 projects, which are listed on the AIFA website https://www.allergyimmunology.org.au/projects/projects#latest 

  • $90,000 awarded to 7 research projects in 2023
  • $115,000 awarded to 4 research projects in 2022
  • $127,000 awarded to 5 research projects in 2021
  • $110,000 awarded to 5 research projects in 2020. 
  • $120,000 awarded to 5 research projects in 2019.
  • $157,160 awarded to 8 research projects from 2015-2018.

AIFA grant rounds open in March/April and are announced at the ASCIA Annual Conference in September. Expression of interest (EOI) forms are on the AIFA website www.allergyimmunology.org.au/grants  

To be eligible for an AIFA grant the Chief Investigator must be an ASCIA member and the research needs to be carried out by the chief investigator and designated team in a non-profit institution in Australia or New Zealand. 

Why support AIFA research grants in 2024-2025? 
  • AIFA is the only charity in Australia and New Zealand which specifically funds allergy and immunology research, and is backed by ASCIA.
  • Continued funding of research is vital for the prevention and treatment of allergy, immunodeficiency and other immune system disorders, and to ultimately find cures. 
  • AIFA research grants are awarded through a robust selection process by an independent and voluntary expert AIFA grant selection panel.
  • Supporters of AIFA research grants can be assured that 100% of sponsorship and donations to AIFA directly fund research.
  • AIFA recognises sponsors and donors, with donations of $100 perpetually acknowledged on the AIFA website https://www.allergyimmunology.org.au/our-supporters/donors
  • Significant supporters of $10,000 or more are entitled to AIFA named grants.

AIFA named grant sponsors receive additional benefits:

  • Association with ASCIA, the peak professional body for allergy and clinical immunology in Australia and New Zealand, as a supporter of medical research that aims to benefit people with allergy, immunodeficiency and other immune system disorders.
  • Acknowledgement on the AIFA website and in communications from AIFA and ASCIA promoting the AIFA grants before and after the grants are awarded.
  • Acknowledgement in the AIFA Research Symposium at the ASCIA Annual Conference, which has been held each year since 2021.
  • The option to target research in specific clinical areas - allergy, immunodeficiency or autoimmunity.

AIFA research grants encourage:

  • Collaborative research projects connecting networks in Australia and New Zealand.
  • Emerging researchers through Early Career Research Grants.
  • Innovative research that requires seed funding which can lead to future funding from the NHMRC, MRFF and other organisations.
  • Projects that will translate to better treatment and care for patients with allergy, immunodeficiency and other immune system disorders.

AIFA and ASCIA are registered with the Australian Charities and Not-for-profits Commission (ACNC)

ABN  45 615 521 452

Donations to AIFA are tax deductible and can be made online at https://www.allergyimmunology.org.au/donate

To find out how you can support AIFA research grants in 2024-2025, please email This email address is being protected from spambots. You need JavaScript enabled to view it.

Content updated January 2024